Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Healthcare Biotechnology
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Advanced Proteome Therapeutics Corporation > Covid news!!!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Whaaaaat1on Jul 13, 2020 12:27pm
123 Views
Post# 31260896

RE:RE:RE:RE:Covid news!!!

RE:RE:RE:RE:Covid news!!!
Yes, they work on protein (Abs) conjugation, but the COVID-19 program involves proprietary antivirals (based upon a compound that has been approved for use in humans)...it's already generated (provisional) IP (as per the news release). 

This program is pretty simple...they will build the molecules and then test them against the virus in cell lines and animals...results in a couple of months...it works or it doesn't...fast....  What more do you want from a company with a $4MM market cap?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities